Millennium Pharmaceuticals

                   

Learn about the World Biotechnology Market Brief (Business Wire)

yahoo.com
19 mins ago 14 related
        

Tuesday November 18, 8:27 am ET NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. Market (2003):...

add comment
                   

Japan M&A: Prescription for growth

financeasia.com
yesterday 2 related
        

By Sameera Anand | 17 November 2008 The cross-border acquisitions that Japan’s pharmaceutical companies are announcing could be just what the doctor ordered, even though they come with hefty price tags. Japanese pharmaceutical...

add comment
                   

HMS Codifies COI Policies

thecrimson.com
14-Nov-2008 1 related
        

In early September, the first-year Harvard Medical School students in a biochemistry class expected to learn about protein degradation. Instead, they came out of lecture ready to push for more comprehensive conflict of interest...

add comment

KU Center for Research sues NCI about anti-cancer patent

bizjournals.com
12-Nov-2008 4 related
        

A day before the University of Kansas Cancer Center was scheduled to make a formal application for designation from the National Cancer Institute, the NCI was named as a defendant in a patent-related lawsuit brought by another...

add comment
                   

Celgene: Blockbuster Biotech Bet

istockanalyst.com
10-Nov-2008
        

"The medical arena has long been my favorite sectors; perhaps the best opportunities within the medical sector will be with companies who provide life-saving products for the treatment of serious diseases," says Dave Dyer. In...

add comment
                   

Bristol-Myers Gambles On Kosan (at Forbes.com)

yahoo.com
10-Nov-2008 3 related
        

Bristol-Myers Squibb is trying to regain its throne as the leading provider of cancer treatments now that its drug Taxol has a slew of generic copycats eating into its sales. But it may be trying too hard: an takeover announced...

add comment

Value of M&As leaps as Japan goes shopping

thejapannews.net
08-Nov-2008 2 related
        

The value of Japanese mergers and acquisitions targeting overseas companies more than tripled to a record of ¥6.67 trillion between January and October, a private survey showed Saturday. The figures suggest Japanese companies...

add comment
                   

More R&D: Not Boosting Big Pharma - BusinessWeek

businessweek.com
07-Nov-2008
        

Despite stepped-up levels of research spending, drug outfits are launching fewer new products, says S&P Drug industry R&D spending, by U.S. members of PhRMA, an industry trade group, expanded 20% from 2004 through 2007. No Help...

add comment

Global Drug Discovery Technologies Market to Exceed $57B By 2012, According To A New Report By...

drugdiscoveryonline.com
05-Nov-2008 1 related
        

Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D

add comment
                   

Compugen and Millennium seek protein pathways

globes.co.il
05-Nov-2008
        

Compugen VP commercial operations Lior D. Ma'ayan: “We are entering a new field with a partner who brings both substantial know-how and human capital." Moran Bar-Kochva25 Mar 02 11:46 Compugen (Nasdaq: CGEN ) and Millennium...

add comment
1 2 3 next